By barely changing their products, they obtained over 130 patents that gave them continued exclusive market control over over rheumatoid arthritis treatments. And During this time, the price from Humira went from $500 for one syringe to nearly $3,000 per syringe. And that led to about $80,000 for a one year supply for a patient. In fact, Abbvie isn't the only one doing this. I have an example right here from AstraZeneca. (03:38–03:51)
CLAIM
Asserts that the price of Humira increased from $500 to nearly $3,000 per syringe.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
